Analyses of human study databases showed that eIF6 levels increase in NAFLD progression, unlike structural proteins of the small and large ribosomal subunits, while eIF1, eIF4B and eIF3A levels decrease. The gene discussed is EIF4B; the disease is metabolic dysfunction-associated steatotic liver disease.